| Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673) |
|---|
| 05/13/1998 | CN1181720A Remotely programmable matrices with memories and uses thereof |
| 05/12/1998 | US5750088 Stable hydrazones linked to a peptide moiety as reagents for the preparation of radiopharmaceuticals |
| 05/07/1998 | WO1998005363A3 Polypeptides having a single covalently bound n-terminal water-soluble polymer |
| 05/07/1998 | DE19740263A1 Kachelungsverfahren zum Bauen eines chemischen Arrays Kachelungsverfahren for building a chemical arrays |
| 05/05/1998 | US5747654 Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
| 05/05/1998 | US5747646 Polyethylene-protein conjugates |
| 05/05/1998 | US5747639 Use of hydrophobic interaction chromatography to purify polyethylene glycols |
| 05/05/1998 | US5747457 Linear adhesion inhibitors |
| 05/05/1998 | US5747451 Diagnosis and prevention of arteriosclerosis |
| 04/29/1998 | EP0838472A1 Peptides binding to low-density lipoproteins |
| 04/28/1998 | US5744305 Arrays of materials attached to a substrate |
| 04/28/1998 | US5744101 Reactor system for synthesizing polymer sequences on substrate; solid phase synthesis |
| 04/22/1998 | EP0796403A4 Functionalized nanotubes |
| 04/21/1998 | US5741686 Exopeptidase catalyzed site-specific bonding of supports, labels and bioactive agents to proteins |
| 04/16/1998 | WO1998015833A1 Methods and means for selecting peptides and proteins having specific affinity for a target |
| 04/16/1998 | WO1998015658A1 Compositions and methods for treating viral infections |
| 04/16/1998 | WO1998015572A1 A composition comprising an immobilised, acylated peptide |
| 04/16/1998 | CA2267139A1 Methods and means for selecting peptides and proteins having specific affinity for a target |
| 04/15/1998 | CN1038035C Preparing method for polyethylene protein conjugates |
| 04/14/1998 | US5739386 Photolabile compounds and methods for their use |
| 04/14/1998 | US5739350 CC-1065 analogs |
| 04/09/1998 | WO1998014463A1 MAGE-10 ENCODING cDNA, THE TUMOR REJECTION ANTIGEN PRECURSOR MAGE-10, ANTIBODIES SPECIFIC TO THE MOLECULE, AND USES THEREOF |
| 04/09/1998 | CA2267202A1 Mage-10 encoding cdna, the tumor rejection antigen precursor mage-10, antibodies specific to the molecule, and uses thereof |
| 04/08/1998 | EP0834576A2 Methods using nucleic acid hybridization patterns on a matrix of oligonucleotides |
| 04/08/1998 | EP0834575A2 Methods using target nucleic acid hybridization patterns on a matrix of oligonucleotides |
| 04/08/1998 | EP0833941A1 Polypeptides having a functional domain of interest and methods of identifying and using same |
| 04/08/1998 | EP0439508B1 Polyethylene glycolcol (peg)-protein adducts and process for their fractionation |
| 04/07/1998 | US5736139 Treatment of Clostridium difficile induced disease |
| 04/02/1998 | DE19742156A1 Thin films containing functional molecules |
| 04/01/1998 | EP0832096A1 Synthesis of proteins by native chemical ligation |
| 04/01/1998 | EP0832068A1 Stable reagents for the preparation of radiopharmaceuticals |
| 03/31/1998 | US5733538 Surface-modifying copolymers having cell adhesion properties |
| 03/26/1998 | WO1998012561A1 Diagnostics for and mediators of inflammatory disorders |
| 03/26/1998 | CA2237191A1 Diagnostics for and mediators of inflammatory disorders |
| 03/24/1998 | US5730990 Non-antigenic amine derived polymers and polymer conjugates |
| 03/18/1998 | CN1176658A Vaccine and antitoxin for treatment and prevention of C. difficile disease |
| 03/12/1998 | WO1998009735A1 Method of oriented depositing chemically defined bodies |
| 03/12/1998 | WO1997046259A3 Chimeric toxin for targeted therapy |
| 03/11/1998 | CN1175465A Process for manufacture of pharmaceutical composition containing polyethylene glycol protein conjugates |
| 03/10/1998 | US5726243 Mild solid-phase synthesis of aligned, branched triple-helical peptides |
| 03/10/1998 | US5726023 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
| 03/04/1998 | EP0554389B1 Molecular clones of hiv-1 and uses thereof |
| 03/03/1998 | US5723588 Heat stable resin with polypeptides such as elastin, collagen with keratin or silk proteins |
| 03/03/1998 | US5723579 Fibrinogen binding peptides |
| 03/03/1998 | US5723297 Process for detecting an antibody using a nucleic acid amplification probe |
| 02/26/1998 | CA2232239A1 Mammaglobin, antibodies thereto, and their use for detecting diseases of the breast |
| 02/19/1998 | WO1998006737A1 Long wavelength engineered fluorescent proteins |
| 02/18/1998 | CN1173500A PEG-interferon conjugates |
| 02/17/1998 | US5719267 Clostridial toxin disease therapy |
| 02/17/1998 | US5718915 Antiviral liposome having coupled target-binding moiety and hydrolytic enzyme |
| 02/12/1998 | WO1998005363A2 Polypeptides having a single covalently bound n-terminal water-soluble polymer |
| 02/12/1998 | CA2262994A1 Polypeptides having a single covalently bound n-terminal water-soluble polymer |
| 02/11/1998 | EP0822861A1 Remotely programmable matrices with memories and uses thereof |
| 02/11/1998 | EP0822828A1 Isolated 55 to 75 kda protein which binds to prion protein |
| 02/10/1998 | US5717075 Formed by reacting membrane that has bound carboxylic acid groups with 2-ethyl-5'-phenylisoxazolium sulfonate |
| 02/04/1998 | EP0822199A2 N-terminally monopegylated polypeptides and process for their preparation. |
| 02/03/1998 | US5714581 Antitumor agents, leukemia treatment |
| 02/03/1998 | US5714360 Crosslinking a surface with a target molecule; biological immobilization; medical equipment; surface treatment |
| 02/03/1998 | US5714166 Bioactive and/or targeted dendrimer conjugates |
| 01/28/1998 | EP0474789B1 Cysteine thiol-protected peptides for use in immunoassays |
| 01/27/1998 | US5712367 Coupling with lipophilic substituent |
| 01/27/1998 | US5711944 Interferon polymer conjugates |
| 01/22/1998 | DE19629206A1 Polymerisable poly:amide derivatives containing double bonds |
| 01/20/1998 | US5710130 Heterocyclic synthetic peptides |
| 01/20/1998 | US5709995 Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses |
| 01/15/1998 | WO1998001496A1 Azlactone-derivatized polyamides |
| 01/15/1998 | WO1998001466A1 Imprint polypeptides covalently cross-linked and having a fixed and stabilised arrangement, process for the preparation and use thereof |
| 01/15/1998 | CA2259416A1 Imprint polypeptides covalently cross-linked and having a fixed and stabilised arrangement, process for the preparation and use thereof |
| 01/14/1998 | EP0817846A1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies |
| 01/08/1998 | WO1998000531A1 Preparation of ionically cross-linked polyphosphazene microspheres by coacervation |
| 01/08/1998 | WO1998000156A1 Synthetic phosphopeptides for treating bone diseases |
| 01/08/1998 | WO1997033995A3 Extracellular matrix signalling molecules |
| 01/08/1998 | DE19624990A1 Production of polymer compounds with activated amino groups |
| 01/08/1998 | CA2258286A1 Preparation of ionically cross-linked polyphosphazene microspheres by coacervation |
| 01/07/1998 | EP0716609A4 METHODS AND COMPOSITIONS FOR STIMULATING AND INHIBITING TGF--g(b) ACTIVITY |
| 01/06/1998 | US5705612 NEF peptide encoded by human immunodefiency virus type 1 (HIV-1) |
| 12/17/1997 | CN1167777A Interferon conjugates |
| 12/16/1997 | US5697902 Treating patient with antibody or antibody fragment conjugated to cytotoxic agent |
| 12/11/1997 | WO1997046590A1 Materials and methods for the immobilization of bioactive species onto polymeric substrates |
| 12/11/1997 | WO1997046259A2 Chimeric toxin for targeted therapy |
| 12/09/1997 | US5695994 Isolated cytolytic T cells specific for complexes of MAGE related peptides and HLA molecules |
| 12/03/1997 | EP0809996A2 Interferon conjugates |
| 11/27/1997 | WO1997044052A1 Immunomodulating compounds comprising d-isomers of amino acids |
| 11/27/1997 | CA2258698A1 Immunomodulating compounds comprising d-isomers of amino acids |
| 11/26/1997 | CN1166204A Process for immobilizing bio-material on a substrate |
| 11/25/1997 | US5691152 Stable avidin composition |
| 11/25/1997 | US5691060 Biocompatible |
| 11/25/1997 | CA2099865C Hepatic growth factor receptor is the met proto-oncogene |
| 11/18/1997 | US5688760 Polypeptides having bone resorption inhibitory activity comprising PTHrP-derived sequences |
| 11/13/1997 | WO1997032607A3 Activated linkers and methods for making and purifying the same |
| 11/12/1997 | EP0805691A2 Immunogenic conjugate molecules |
| 11/12/1997 | EP0734530B1 Combinatorial libraries and methods for their use |
| 11/11/1997 | US5686278 Methods for enhanced retrovirus-mediated gene transfer |
| 11/06/1997 | WO1997032598A3 Vaccines |
| 11/05/1997 | EP0804728A1 Assay, receptor proteins and ligands |
| 11/05/1997 | EP0804595A1 Synthetic proteins as implantables |
| 11/05/1997 | EP0804580A1 Calcium binding recombinant antibody against protein c |
| 11/05/1997 | EP0804219A1 Inhibin compositions and methods of use thereof |
| 11/04/1997 | US5684145 Carrier system against GNRH |
| 10/30/1997 | WO1997040147A1 Antigenically reactive regions of the hepatitis a virus polyprotein |